跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,709 条关于
“Altos Therapeutics”
全部
16,709
临床试验
3,625
药物
3,130
机构
1,131
资讯
8,823
2年前
TAK-906: Peripheral D2/D3 Antagonist Under Development for Gastroparesis
2年前
Novel Drug Candidates Target Diverse Diseases: Malaria, Gastroparesis, and Cancer
3年前
Alteogen's Subsidiary Completes Phase III Enrollment for Eylea Biosimilar in Wet AMD
去年
Longevity Biotechs Attract $4.8 Billion Investment as Companies Target Aging Mechanisms Over Life Extension
2年前
Alteogen Seeks Approval for Aflibercept Biosimilar ALT-L9 in Korea
去年
Alteogen's Aflibercept Biosimilar Eyluxvi Receives Positive Opinion from European Medicines Agency
23天前
Daewoong Pharmaceutical Secures U.S. Patent Allowance for mRNA Anti-Aging Delivery Technology
2年前
AI and Multi-Omics Drive Breakthrough Advances in Anti-Aging Drug Development
去年
Sandoz's Aflibercept Biosimilar Afqlir Gains European Commission Approval
7个月前
Life Biosciences Secures First FDA Approval for Human Epigenetic Reprogramming Trial to Reverse Vision Loss
第 1 页,共 883 页
上一页
下一页